Detection of Advanced Colorectal Neoplasia by Stool DNA in Inflammatory Bowel Disease

CompletedOBSERVATIONAL
Enrollment

440

Participants

Timeline

Start Date

March 31, 2013

Primary Completion Date

January 31, 2017

Study Completion Date

January 31, 2017

Conditions
Inflammatory Bowel Disease (IBD)Primary Sclerosing Cholangitis (PSC)Colorectal NeoplasmsColorectal Cancer
Trial Locations (26)

10029

Mount Sinai School of Medicine, New York

10075

Medical Research Associates of New York, New York

20815

MGG Group, Co. Inc./Chevy Chase Clinical Research, Chevy Chase

24502

Blue Ridge Medical Research, Lynchburg

27599

Univeristy of North Carolina, Chapel Hill

28801

Asheville Gastroeneterology Associates, Asheville

33136

University of Miami, Miami

44195

Cleveland Clinic, Cleveland

48334

Detroit Clinical Research Center, PC, Farmington Hills

53215

Wisconsin Center for Advanced Research, Milwaukee

53792

University of Wisconsin Hospital and Clinics, Madison

55905

Mayo Clinic, Rochester

60201

NorthShore University Health System, Evanston

60612

Rush University Medical Center, Chicago

60637

University of Chicago Medicine, Chicago

65265

Center for Digestive and Liver Diseases, Inc, Mexico

70809

Gastroenterology Associates, LLC, Baton Rouge

77030

Houston Methodist Hospital, Houston

84341

Advanced Research Institute, Logan

85054

Mayo Clinic Arizona, Phoenix

92093-0956

UC San Diego Medical Center, La Jolla

02114

Massachusetts General Hospital, Boston

02118

Boston Medical Center, Boston

37212-1610

Vanderbilt University Medical Center, Nashville

T2N 1N4

University of Calgary, Calgary

R3A 1R9

Winnipeg Regional Health Authority-Health Sciences, Winnipeg

Sponsors
All Listed Sponsors
lead

Exact Sciences Corporation

INDUSTRY

NCT01819766 - Detection of Advanced Colorectal Neoplasia by Stool DNA in Inflammatory Bowel Disease | Biotech Hunter | Biotech Hunter